What are future directions for research at the intersection of Mycobacterium tuberculosis and toxicology?
Research at the intersection of Mtb and toxicology is focused on several key areas. Developing new therapeutics that target bacterial virulence factors with minimal host toxicity is a priority. Additionally, investigating the role of environmental pollutants in TB pathogenesis could lead to public health interventions. Finally, understanding the molecular mechanisms of drug toxicity can aid in designing safer treatment regimens.
In conclusion, while Mtb is primarily an infectious agent, its study within the realm of toxicology provides vital insights into host-pathogen interactions, treatment challenges, and future therapeutic developments. Addressing the toxicological aspects of TB is crucial for improving patient outcomes and combating this global health threat.
